Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Change in Acquisitions & Divestments: 2015-2025

Historic Change in Acquisitions & Divestments for Syndax Pharmaceuticals (SNDX) over the last 11 years, with Sep 2025 value amounting to $103.0 million.

  • Syndax Pharmaceuticals' Change in Acquisitions & Divestments rose 2.79% to $103.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $448.6 million, marking a year-over-year increase of 30.82%. This contributed to the annual value of $337.3 million for FY2024, which is 28.58% down from last year.
  • According to the latest figures from Q3 2025, Syndax Pharmaceuticals' Change in Acquisitions & Divestments is $103.0 million, which was down 22.90% from $133.6 million recorded in Q2 2025.
  • In the past 5 years, Syndax Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $154.9 million in Q2 2023 and a low of $37.5 million during Q1 2021.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $104.7 million (2025), whereas its average is $104.6 million.
  • Per our database at Business Quant, Syndax Pharmaceuticals' Change in Acquisitions & Divestments spiked by 363.73% in 2021 and then crashed by 60.14% in 2024.
  • Quarterly analysis of 5 years shows Syndax Pharmaceuticals' Change in Acquisitions & Divestments stood at $45.4 million in 2021, then spiked by 149.45% to $113.2 million in 2022, then dropped by 0.22% to $113.0 million in 2023, then dropped by 5.01% to $107.3 million in 2024, then rose by 2.79% to $103.0 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $103.0 million for Q3 2025, versus $133.6 million for Q2 2025 and $104.7 million for Q1 2025.